Venular thrombosis is the key event in the pathogenesis of antibody- mediated cardiac rejection

Xenotransplantation

Volumn 7, Issue 1, 2000, Pages 31-41

  Rose, Alan G ^a,c   Cooper, David K C ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Allograft; Antibody mediated rejection; Cardiac xenograft; Hyperacute rejection; Venous thrombosis; Venular endothelial mediators of inflammation

Indexed keywords

ANTIBODY;

ANIMAL TISSUE; ARTICLE; GRAFT REJECTION; HEART INFARCTION; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; THROMBOGENESIS; VEIN THROMBOSIS; XENOGRAFT;

ANIMALS; ANTIBODIES, HETEROPHILE; CAPILLARIES; CELL MOVEMENT; CORONARY VESSELS; EDEMA; ENDOCARDIUM; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNITY, CELLULAR; ISOANTIBODIES; LEUKOCYTES; PAPIO; SWINE; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS; VENOUS THROMBOSIS;

EID: 0034013386     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3089.2000.00042.x     Document Type: Article

References (36)

1. COOPER DKC, KEMP E, PLATT J, WHITE DJG, eds. Xenotransplantation (2nd edn). Heidelberg: Springer, 1997.
2. LEXER G, COOPER DKC, ROSE AG et al. Hyperacute rejection in a discordant (pig-to-baboon) cardiac xenograft model. J Heart Transplant 1986; 5: 411.
3. COOPER DKC, HUMAN PA, LEXER G et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 1998; 7: 238.
4. GOOD AH, COOPER DKC, MALCOLM AJ et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559.
5. COOPER DKC, HUMAN PA, ROSE AG. et al. The role of ABO blood group compatibility in heart transplantation between closely-related animal species. An experimental study using the vervet monkey-to-baboon cardiac xenograft model. J Thorac Cardiovasc Surg 1989; 97: 447.
6. REICHENSPURNER H, HUMAN PA, BOEHM DH. et al. Optimalization of immunosuppression after xenogeneic heart transplantation in primates. J Heart Transplant 1989; 8: 200.
7. KEMP E. Experimental xenotransplantation between distantly related nonprimate species. In: COOPER DKC, KEMP E, REEMTSMA K, WHITE DJG, eds. Xenotransplantation (1st edn). Heidelberg: Springer, 1991; 377.
8. KOBAYASHI T, TANIGUCHI S, NEETHLING FA et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 1997; 64: 1255.
9. ROSE AG. Histopathology of cardiac xenograft rejection. In: COOPER DKC, KEMP E, REEMTSMA K, WHITE DJG, eds. Xenotransplantation (1st edn). Heidelberg: Springer, 1991; 231.
10. CATTELL V, JAMIESON SW. Hyperacute rejection of guinea-pig to rat cardiac xenografts. I Morphology. J Pathol 1975; 115: 183.
11. FORBES RDC, GUTTMANN RD, BAZIN H. Hyperacute rejection of cardiac allografts in a rat strain with a hereditary platelet function deficit. Lab Invest 1977; 37: 158.
12. FORBES RDC, KURAMOCHI T, GUTTMANN RD, KLASSEN J, KNAACK J. A controlled sequential morphologic study of hyperacute cardiac allograft rejection in the rat. Lab Invest 1975; 33: 280.
13. KOBAYASHI T, NEETHLING F, KOREN E, TAKAGI H, COOPER DKC. In vitro and in vivo investigation of the potential roles of the anticomplement agents, FUT-176 and K76COOH, in the prevention of hyperacute rejection following discordant xenotransplantation. Transplant Proc 1996; 28: 604.
14. COOPER DKC, HUMAN PA, REICHART B. Prolongation of cardiac xenograft (vervet monkey-to-baboon) function by a combination of total lymphoid irradiation and immunosuppressive drug therapy. Transplant Proc 1987; 19: 4441.
15. BARNARD CN, WOLPOWITZ A, LOSMAN JG. Heterotopic cardiac transplantation with a xenograft for assistance of the left heart in cardiogenic shock after cardiopulmonary bypass. S Afr Med J 1977; 52: 1035.
16. COOPER DKC, LEXER G, ROSE AG. et al. Cardiac allotransplantation across major blood group barriers in the baboon. J Med Primatol 1988; 17: 333.
17. COOPER DKC, HARRIS N, ROSE AG, NOVITZKY D. Accelerated cardiac allograft rejection associated with administration of liver cell extract in the baboon. Transplant Proc 1990; 22: 1966.
18. LANZA RP, CAMPBELL EM, COOPER DKC. et al. Problem of the presensitized heart transplant recipient. J Heart Transplant 1983; 2: 151.
19. COOPER DKC, YE Y, NIEHRASZ M. et al. Specific intravenous carbohydrate therapy - a new concept in inhibiting antibody-mediated rejection: experience with ABO-incompatible cardiac allografting in the baboon. Transplantation 1993; 56: 769.
20. FORBES RD, GUTTMANN RD, KURAMOCHI T. et al. Nonessential role of neutrophils as mediators of hyperacute cardiac allograft rejection in the rat. Lab Invest 1976; 34: 229.
21. MULLERWORTH MH, LIXFELD W, RACHKEWICH RA. et al. Hyperacute rejection of heterotopic heart allografts in dogs. Transplantation 1972; 13: 570.
22. WIGHT DGD. Histopathology of liver xenograft rejection. In: COOPER DKC, KEMP E, REEMTSMA K, WHITE DJG, eds. Xenotransplantation (1st edn). Heidelberg: Springer, 1991; 253.
23. FORBES RD, GUTTMANN RD. Evidence for complement-induced endothelial injury in vivo: a comparative ultrastructural tracer study in a controlled model of hyperacute rat cardiac allograft rejection. Am J Pathol 1982; 106: 378.
24. FORBES RD, GUTTMANN RD, PINTO-BLONDE M. A passive transfer model of hyperacute rat cardiac allograft rejection. Lab Invest 1979; 41: 348.
25. DEBAULT L, YE Y, ROLF LL. et al. Ultrastructural features in hyperacutely rejected baboon cardiac allografts and pig xenografts. Transplant Proc 1992; 24: 612.
26. ROSE AG, COOPER DKC. Ultrastructure of hyperacute rejection in cardiac xenografts. In: COOPER DKC, KEMP E, REEMTSMA K, WHITE DJG, eds. Xenotransplantation (1st edn). Heidelberg: Springer, 1991; 243.
27. BILLINGHAM ME. Normal heart. In: STERNBERG SS, ed. Histology for Pathologists. New York: Raven Press, 1992; 215.
28. ROSE AG, COOPER DKC. A histopathologic grading system of hyperacute (humoral, antibody-mediated) cardiac xenograft and allograft rejection. J Heart Lung Transplant 1996; 15: 804.
29. HASSANEIN AM, ATKINSON BF. USMLE Pathology Review. The Study Guide. London: Sage Publications, 1998; 26.
30. LEMSTROM K, KOSKINEN P, HAYRY P. Induction of adhesion molecules on the endothelia of rejecting cardiac allografts. J Heart Transplant 1995; 14: 205.
31. CHEN RH, MITCHELL RN, KADNER A, ADAMS DH. Differential galactose α (1, 3) galactose expression byporcine cardiac vascular endothelium. Xenotransplantation 1999; 6: 169.
32. DVORAK HF, BROWN LF, DETMAR M, DVORAK AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029.
33. CALNE RY, DAVIS DR, HADJIYANNAKIS E. et al. Immunosuppressive effects of soluble cell membrane fractions, and donor blood and serum on renal allograft survival. Nature 1970; 227: 903.
34. YE Y, NEETHLING FA, NIEKRASZ M. et al. Evidence that intravenously administered alpha-galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation 1994; 58: 330.
35. SABLINSKI T, LATINNE D, GIANELLO P. et al. Xenotransplantation of pig kidneys in nonhuman primates: I. Development of the model. Xenotransplantation 1995; 2: 264.
36. COOPER DKC, CAIRNS TDH, TAUBE DH. Extracorporeal immunoadsorption of anti-pig antibody in baboons using α-Gal oligosaccharide immunoaffinity columns. Xenotransplantation 1996; 4: 27.